Skip to main content
GNMX logo

Corgi Genomics & Precision Medicine ETF (GNMX)

GNMXBATSCorgiEquity

$32.06Today:−$0.38 (−1.17%)

As of Nov 20, 2026 close

Assets (AUM)
$2.80M
Expense ratio
0.35%
Dividend yield
-
Holdings
59
52-week range
$23.88$39.86
Volume (live)
-
Avg. volume (3M)
1.21K

GNMX ETF Holdings: Corgi Genomics & Precision Medicine ETF

The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.

Total Holdings
59
Updated Oct 4, 2026
Top 10 Holdings
48.4%
Share of fund assets
Assets (AUM)
$2.80M
Total fund assets
Expense Ratio
0.35%
Annual management fee

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 25 of 59 GNMX Holdings by Portfolio Weight

Holdings data last updated Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 25 positions.

Scroll to see more
GNMX ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage, sorted by portfolio weight, last updated Oct 4, 2026.
#SymbolNameTypeWeight
1
TMO logo
TMO
Thermo Fisher Scientific IncStock8.45%
2
MRNA logo
MRNA
Moderna, Inc.Stock8.40%
3
VRTX logo
VRTX
Vertex Pharmaceuticals IncorporatedStock6.52%
4
ILMN logo
ILMN
Illumina, Inc.Stock4.70%
5
TXG logo
TXG
10x Genomics, Inc.Stock3.85%
6
GH logo
GH
Guardant Health, Inc.Stock3.65%
7
RVMD logo
RVMD
Revolution Medicines, IncStock3.64%
8
TWST logo
TWST
Twist Bioscience CorporationStock3.12%
9
IOVA logo
IOVA
Iovance Biotherapeutics, Inc.Stock3.10%
10
INCY logo
INCY
Incyte CorporationStock2.95%
11
GMAB logo
GMAB
Genmab A/SStock2.88%
12
ALNY logo
ALNY
Alnylam Pharmaceuticals, IncStock2.75%
13
MUTF:FGXXX
First American Government Obligs XStock2.56%
14
TECH logo
TECH
Bio-Techne CorporationStock2.13%
15
GRAL logo
GRAL
GRAIL, Inc.Stock2.13%
16
BMRN logo
BMRN
BioMarin Pharmaceutical Inc.Stock1.97%
17
TEM logo
TEM
Tempus AI, Inc.Stock1.93%
18
CDNA logo
CDNA
CareDx, Inc.Stock1.92%
19
QGEN logo
QGEN
Qiagen N.V.Stock1.76%
20
KRYS logo
KRYS
Krystal Biotech, Inc.Stock1.74%
21
ADPT logo
ADPT
Adaptive Biotechnologies CorporationStock1.73%
22
SDGR logo
SDGR
Schrödinger, Inc.Stock1.49%
23
ARWR logo
ARWR
Arrowhead Pharmaceuticals, Inc.Stock1.42%
24
CRSP logo
CRSP
CRISPR Therapeutics AGStock1.40%
25
NEO logo
NEO
NeoGenomics, Inc.Stock1.39%

Source: Fund holdings disclosures. Last updated Oct 4, 2026. Data sources and methodology

Frequently Asked Questions About Corgi Genomics & Precision Medicine ETF Holdings

What are the top holdings in GNMX?

In holdings data last updated Oct 4, 2026, GNMX's largest holdings are Thermo Fisher Scientific Inc (TMO) at 8.45%, Moderna, Inc. (MRNA) at 8.40%, Vertex Pharmaceuticals Incorporated (VRTX) at 6.52%, Illumina, Inc. (ILMN) at 4.70% and 10x Genomics, Inc. (TXG) at 3.85%. Together these 5 positions make up 31.9% of the fund. GNMX holds 59 securities in all; the holdings data lists the top 25 by weight.

How concentrated is GNMX's portfolio?

In holdings data last updated Oct 4, 2026, the 10 largest of GNMX's 59 positions make up 48.4% of assets. The largest single position is Thermo Fisher Scientific Inc (TMO) at 8.45%. The top 25 listed positions add up to 77.6%, so the remaining 34 holdings share 22.4%. Its largest sector, Healthcare, is 100.0% of the portfolio.

What is GNMX's sector allocation?

In holdings data last updated Oct 4, 2026, GNMX's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.

What countries does GNMX invest in?

In holdings data last updated Oct 4, 2026, 92.6% of GNMX's portfolio is invested in the United States, followed by Denmark (2.8%), Netherlands (2.6%) and Switzerland (2.0%). GNMX has exposure to 4 countries in total.